España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cannara Biotech
LOVFF
OTCQB
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Cannara Biotech (LOVFF) Forecast
News
Earnings
Cannara Biotech (LOVFF) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cannara Biotech (OTC:LOVFF) Stock
Cannara Biotech Stock (OTC: LOVFF)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 06, 2024
AP Reports Florida Voters Reject Cannabis Leg...
Benzinga Newsdesk
Wednesday, October 30, 2024
Microsoft shares are trading higher after the...
Benzinga Newsdesk
Tuesday, October 29, 2024
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground
Nicolás Jose Rodriguez
Tuesday, July 23, 2024
Cannara Biotech Reports 6% YoY Drop In Q3 Gross Profit, 22% Revenue Increase As It Enhances Sales Force And Infrastructure
Jelena Martinovic
Monday, June 03, 2024
Cannabis Slowdown In Canada: Analyst Spotlights What Still Sells And Where The Money Is Going
Nicolás Jose Rodriguez
Wednesday, May 01, 2024
Cannara Biotech Reports 51% YoY Revenue Increase In Q2, Wider Net Loss
Jelena Martinovic
Wednesday, February 07, 2024
Cannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export Sale
Meg Flippin
-
Sponsored
Tuesday, December 12, 2023
Cannara Biotech Market Share Gains Result In Record-Setting Fourth Quarter
Meg Flippin
-
Sponsored
Thursday, December 07, 2023
This Cannabis Producer Reports It Is Able to Deliver Some Of The Highest Quality Product To Market At Some Of The Most Competitive Prices
Johnny Rice
Monday, August 21, 2023
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 21, 2023
Benzinga Insights
Thursday, August 10, 2023
Cannabis Stock Movers For August 10, 2023
Benzinga Insights
Friday, August 04, 2023
Cannabis Stock Gainers And Losers From August 4, 2023
Benzinga Insights
Tuesday, August 01, 2023
Marijuana Stock Movers For August 1, 2023
Benzinga Insights
Thursday, July 27, 2023
Cannabis Stock Movers For July 27, 2023
Benzinga Insights
Cannara Biotech Q3 FY23 Net Revenue Grows 57% YoY, What About Adjusted EBITDA?
Vuk Zdinjak
Tuesday, July 25, 2023
Cannabis Stock Gainers And Losers From July 25, 2023
Benzinga Insights
Thursday, May 04, 2023
Cannara Biotech Secures An Additional $10M In Non-Dilutive Capital With Its Lead Credit Provider, BMO Commercial Banking
Vuk Zdinjak
Monday, April 24, 2023
Cannara Biotech Q2 FY23 Revenue Grows 76% YoY To $9.6M, Here Are The Details
Vuk Zdinjak
Friday, February 10, 2023
Olymbec Investments Increases Its Ownership In Cannara Biotech
Vuk Zdinjak
Monday, January 23, 2023
Cannara Biotech Q1 Revenue Grows 57% YoY To $7.7M, What About Adjusted EBITDA?
Vuk Zdinjak
Monday, November 28, 2022
Cannara Biotech Q4 Revenue Grows 84% YoY To $8.9M
Vuk Zdinjak
Tuesday, September 20, 2022
Cannara Biotech Enters Into The British Columbia Cannabis Market And Launches New Products
Vuk Zdinjak
Wednesday, August 03, 2022
Cannara Biotech Signs An Exclusive Brand Partnership With Exotic Genetix In Canada
Vuk Zdinjak
Wednesday, July 27, 2022
Cannara Biotech Revenue Grows 41% YoY, Here Are The Details
Vuk Zdinjak
Thursday, June 02, 2022
Cannara Biotech Closes $50 Million Credit Facility Led By BMO Commercial Banking
Vuk Zdinjak
Wednesday, April 27, 2022
Cannara Biotech Revenues Grew 229% To $7.4M In Q2 2022 YoY
Vuk Zdinjak
Tuesday, February 01, 2022
New Kids On The Block: Is A Second Wave Of Canadian Cannabis Here?
Johnny Rice
-
Sponsored
Saturday, January 22, 2022
What Was In Cannara Biotech's Q1 Earnings Report?
Javier Hasse
Friday, December 10, 2021
The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
Javier Hasse
Thursday, December 09, 2021
Cannara Biotech Shares Surge On 983% QoQ Revenue Growth, Positive Adjusted EBITDA
Nina Zdinjak
Monday, August 02, 2021
Tilray Best Performer Among Canadian Cannabis LPs, Stocks Plunge Nearly 10% In July
Jelena Martinovic
Thursday, July 29, 2021
Cannara Biotech Cannabis Co. Slightly Beats Estimates, Posts $7.2M In Q3 2021 Revenue
Jelena Martinovic
Friday, July 02, 2021
The Week In Cannabis: Justice Clarence Thomas, Mexico's Decriminalization, Apple's Policy Changes, Tilray And More
Javier Hasse
Monday, June 28, 2021
Cannara Biotech Cannabis Co. Expects To Post $7.1M In Q3 Revenue After Successful Market Launch In Quebec
Jelena Martinovic
Friday, April 17, 2020
Cannabis Earnings Roundup: Avicanna, Cannara Biotech, Halo Labs
Nina Zdinjak
Friday, February 21, 2020
FSD Pharma Sells Cannara Biotech Stake, Netting More Than $7.7M
Javier Hasse
Friday, August 16, 2019
Stocks That Hit 52-Week Highs On Friday
Lisa Levin
Thursday, August 15, 2019
Stocks That Hit 52-Week Highs On Thursday
Lisa Levin
